SynBiotic
SynBiotic focuses on the research and development of cannabinoids for usage in medicinal purposes, cosmetics and dietary supplements.
SynBiotic has raised €10M across 2 funding rounds from 1 investor, most recently a round in Aug 2023. Based in Munich, Germany; active in Agritech and Healthtech. Data as of 28 Oct 2026.
Munich, Germanywww.synbiotic.com ↗
Total raised
€10M
€10,000,000
Funding rounds
2
Investors
1
distinct backers
Active since
2021-10
latest 2023-08
Funding by year
EUR raised per yearSynBiotic — funding by year — interactive chart.
Data table
| SynBiotic — funding by year | |
|---|---|
| 2021 | €7.0M |
| 2023 | €3.0M |
Signals
High confidenceRaise-next likelihood5
base rate 30% for Other
- ▼ Past typical raise window
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood8
base rate 11% (2+ rounds)
- ▲ 5y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: overdue vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-08-22 | Other | €3.0M | Frank Otto | View deal → |
| 2021-10-27 | Other | €7.0M | — | View deal → |
Investors
1Acquisitions
1- Hanf Farm2021
Related news
Similar companies
same sector or countryGlobal coverage: FundingData